MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a ...

Time-restricted eating (TRE), a form of intermittent fasting, helps with improving weight loss, insulin resistance, and body composition. These factors are the functional changes associated with ...

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent ...

A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic ...

A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Modern lifestyles are fueling a surge in fatty liver disease, a condition where excess fat accumulates in the liver. Early ...

What is Fatty Liver? Fatty liver, medically known as hepatic steatosis, occurs when there is an abnormal accumulation of fat ...

Hoth Therapeutics, Inc. , a biopharmaceutical company focused on developing breakthrough therapies for metabolic, dermatologic, and inflammatory diseases, today announced the initiation of a U.S.

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, ...